EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Suppression of cGAS- and RIG-I-mediated innate immune signaling by Epstein-Barr virus deubiquitinase BPLF1

Wai-Yin Lui, Aradhana Bharti, Nok-Hei Mickey Wong, Sonia Jangra, Michael G Botelho, Kit-San Yuen, Dong-Yan Jin iD

PLOS Pathogens · 2023

DOI: 10.1371/journal.ppat.1011186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2023. Verfasst von Wai-Yin Lui und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences, the University of Hong Kong, Pokfulam, Hong Kong. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Herpesvirus 4, Human. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health and Medical Research Fund, Research Grants Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein-Barr virus (EBV) has developed effective strategies to evade host innate immune responses. Here we reported on mitigation of type I interferon (IFN) production by EBV deubiquitinase (DUB) BPLF1 through cGAS-STING and RIG-I-MAVS pathways. The two naturally occurring forms of BPLF1 exerted potent suppressive effect on cGAS-STING-, RIG-I- and TBK1-induced IFN production. The observed suppression was reversed when DUB domain of BPLF1 was rendered catalytically inactive. The DUB activity of BPLF1 also facilitated EBV infection by counteracting cGAS-STING- and TBK1-mediated antiviral defense. BPLF1 associated with STING to act as an effective DUB targeting its K63-, K48- and K27-linked ubiquitin moieties. BPLF1 also catalyzed removal of K63- and K48-linked ubiquitin chains on TBK1 kinase. The DUB activity of BPLF1 was required for its suppression of TBK1-induced IRF3 dimerization. Importantly, in cells stably carrying EBV genome that encodes a catalytically inactive BPLF1, the virus failed to suppress type I IFN production upon activation of cGAS and STING. This study demonstrated IFN antagonism of BPLF1 mediated through DUB-dependent deubiquitination of STING and TBK1 leading to suppression of cGAS-STING and RIG-I-MAVS signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsHerpesvirus 4, HumanHumansDEAD Box Protein 58Deubiquitinating EnzymesImmunity, InnateNucleotidyltransferasesUbiquitin

Substanzen

DEAD Box Protein 58Deubiquitinating EnzymesNucleotidyltransferasesUbiquitin

Autor:innen und Institutionen

  • School of Biomedical Sciences, the University of Hong Kong, Pokfulam, Hong Kong.
  • Faculty of Dentistry, the University of Hong Kong, Sai Yin Pun, Hong Kong.
  • School of Nursing, Tung Wah College, Kowloon, Hong Kong.

ORCID-Profile: Dong-Yan Jin

Förderung

  • Health and Medical Research Fund
  • Research Grants Council

Zitieren

APA

Lui, W. Y., Bharti, A., Wong, N. M., Jangra, S., Botelho, M. G., Yuen, K. S., & Jin, D. Y. (2023). Suppression of cGAS- and RIG-I-mediated innate immune signaling by Epstein-Barr virus deubiquitinase BPLF1. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011186

Vancouver

Lui WY, Bharti A, Wong NM, Jangra S, Botelho MG, Yuen KS, et al. Suppression of cGAS- and RIG-I-mediated innate immune signaling by Epstein-Barr virus deubiquitinase BPLF1. PLOS Pathogens. 2023. doi:10.1371/journal.ppat.1011186

BibTeX
@article{Lui2023,
  author = {Lui, Wai-Yin and Bharti, Aradhana and Wong, Nok-Hei Mickey and Jangra, Sonia and Botelho, Michael G and Yuen, Kit-San and Jin, Dong-Yan},
  title = {Suppression of cGAS- and RIG-I-mediated innate immune signaling by Epstein-Barr virus deubiquitinase BPLF1},
  journal = {PLOS Pathogens},
  year = {2023},
  doi = {10.1371/journal.ppat.1011186}
}
Kostenlos starten →